Loading clinical trials...
Loading clinical trials...
Prospective Cardiac Magnetic Resonance Imaging Study in Duchenne Muscular Dystrophy (DMD-CMP)
The purpose of this study is to describe the progression of tissular and functional myocardial abnormalities in patients with Duchenne muscular dystrophy using cardiac magnetic resonance imaging and blood biomarkers assays.
This study is to describe the progression of tissular (late gadolinium enhancement, T1, T2, ECV assessments) and functional (segmental and global contractility, strain) myocardial abnormalities in patients with Duchenne muscular dystrophy using cardiac magnetic resonance imaging and blood biomarkers assays (troponin I, NTproBNP). Comparison between baseline and 2-years assessments will be conducted.
Age
6 - No limit years
Sex
MALE
Healthy Volunteers
No
Necker Hospital
Paris, France
Start Date
November 1, 2024
Primary Completion Date
February 1, 2029
Completion Date
April 1, 2029
Last Updated
November 20, 2025
Cardiac MRI
DIAGNOSTIC_TEST
Blood assays
BIOLOGICAL
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
NCT07037862
NCT07160634
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06450639